No Surprises Act (H.R. 133)
Verifying Accurate Leading-edge IVCT Development Act of 2020 (S.3404, H.R. 6102)
Temporary Reciprocity to Ensure Access to Treatment Act (S.4421, H.R. 8283) 
Rare Cancer Awareness, Research, and Treatment Act of 2020 (draft, not yet introduced)
Government response to COVID-19, including liability reforms and supply chain issues
Reauthorization of the FDA drug and device user fee programs
Schrems II, government lobbying activities pertaining to data privacy
COVID-19 response; White House COVID-19 Response Team's call to private business
HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 139 - Natl Institutes of Health (NIH) 1 - SENATE 12 - White House Office
FOUNDATION MEDICINE, INC.
150 Second Street, Cambridge, MA, 02141, US
JENNIFER ROMANS